Minnesota Twins return Arraez and Maeda from rehab assignments and reinstate from 10-day injured list

June 14th, 2021

Pineda and Refsnyder placed on 10-day injured list

SEATTLE, WA – The Minnesota Twins announced today that they have returned infielder/outfielder Luis Arraez and right-handed pitcher Kenta Maeda from their rehab assignments and reinstated them from the 10-day Injured List.

Arraez, who missed the last 19 games with a right shoulder strain, played in two games on rehab assignment with Triple-A St. Paul, hitting .250 (2-for-8) with one walk and two RBI. Prior to landing on the Injured List, Arraez played in 39 games for the Twins this season, hitting .277 (39-for-141) with three doubles, one triple, one home run, 14 RBI, 20 runs scored, 17 walks and a .691 OPS.

Maeda, who missed the last 20 games with a right adductor strain, started one game on rehab assignment for the Saints last Wednesday, allowing one run on a solo homer in 4.0 innings pitched, with one walk and five strikeouts. Prior to landing on the Injured List, Maeda made nine starts for the Twins this season, going 2-2 with a 5.27 ERA (42.2 IP, 25 ER), 11 walks and 39 strikeouts. He will make the start tonight for the Twins in Seattle.

To make room for Arraez and Maeda on the 26-man roster, the Twins have placed right-handed pitcher Michael Pineda (right elbow inflammation) and outfielder Rob Refsnyder (left hamstring strain) on the 10-day Injured List. Pineda, who left yesterday’s start vs. the Astros with the injury, has started 11 games for the Twins this season, going 3-4 with a 3.70 ERA (56.0 IP, 23 ER), 15 walks, 51 strikeouts and a 1.14 WHIP. Refsnyder, who left the game last Tuesday vs. the Yankees after a double, has hit .321 (18-for-56) with four doubles, two home runs, 10 RBI and an .871 OPS in 18 games on the season.


Posted in MLB


    Hi , I do believe this is an excellent blog. I stumbled upon it on Yahoo , i will come back once again. Money and freedom is the best way to change, may you be rich and help other people.

Comments are closed.